SafeBoosC III Two-year Follow-up

Clinical trial NCT05134116 · COMPLETED

Trial details

NCT number: NCT05134116
Sponsor: Gorm Greisen
Status: COMPLETED
Study type: OBSERVATIONAL

Deficits, Neurologic Extreme Prematurity Brain Damage

Start date: 2021-09-23
Primary completion: 2024-10-19
Enrollment: 1601

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.